1. Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end‐stage renal disease. Issue 5 (May 2016) Authors: Pedraza, Fernando; Ladino, Marco; Roth, David Journal: Clinical liver disease Issue: Volume 7:Issue 5(2016) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Paraneoplastic glomerular disease: The struggle is real. Issue 1 (February 2019) Authors: Amarapurkar, Pooja; Bou-Slaiman, Salim; Madrid, Bianca; Ladino, Marco Journal: Journal of onco-nephrology Issue: Volume 3:Issue 1(2019) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Transplantation of kidneys from hepatitis C‐positive donors into hepatitis C virus‐infected recipients followed by early initiation of direct acting antiviral therapy: a single‐center retrospective study. (2nd May 2017) Authors: Bhamidimarri, Kalyan R.; Ladino, Marco; Pedraza, Fernando; Guerra, Giselle; Mattiazzi, Adela; Chen, Linda; Ciancio, Gaetano; Kupin, Warren; Martin, Paul; Burke, George; Roth, David Journal: Transplant international Issue: Volume 30:Number 9(2017) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treating hepatitis C virus in dialysis patients: How, when, and why?. Issue 2 (26th November 2018) Authors: Pagan, Javier; Ladino, Marco; Roth, David Other Names: Bloom Roy D. guestEditor.; Roth David guestEditor. Journal: Seminars in dialysis Issue: Volume 32:Issue 2(2019) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗